PIM-1 mRNA expression is a potential prognostic biomarker in acute myeloid leukemia
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
PIM-1 mRNA expression is a potential prognostic biomarker in acute myeloid leukemia
Authors
Keywords
PIM-1, mRNA, Expression, Prognosis, Acute myeloid leukemia
Journal
Journal of Translational Medicine
Volume 15, Issue 1, Pages -
Publisher
Springer Nature
Online
2017-08-29
DOI
10.1186/s12967-017-1287-4
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- High expression of ETS2 predicts poor prognosis in acute myeloid leukemia and may guide treatment decisions
- (2017) Lin Fu et al. Journal of Translational Medicine
- DOT1L as a therapeutic target for the treatment of DNMT3A -mutant acute myeloid leukemia
- (2016) Rachel E. Rau et al. BLOOD
- The PIM1 kinase promotes prostate cancer cell migration and adhesion via multiple signalling pathways
- (2016) Niina M. Santio et al. EXPERIMENTAL CELL RESEARCH
- Genomic Classification and Prognosis in Acute Myeloid Leukemia
- (2016) Elli Papaemmanuil et al. NEW ENGLAND JOURNAL OF MEDICINE
- ‘Acute myeloid leukemia: a comprehensive review and 2016 update’
- (2016) I De Kouchkovsky et al. Blood Cancer Journal
- IDH2 inhibition in AML: Finally progress?
- (2015) Eytan M. Stein BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY
- Acute Myeloid Leukemia
- (2015) Hartmut Döhner et al. NEW ENGLAND JOURNAL OF MEDICINE
- PIM kinase (and Akt) biology and signaling in tumors
- (2015) Noel A. Warfel et al. PHARMACOLOGY & THERAPEUTICS
- Pim Kinases Promote Migration and Metastatic Growth of Prostate Cancer Xenografts
- (2015) Niina M. Santio et al. PLoS One
- PIM1 Kinase Phosphorylates the Human Transcription Factor FOXP3 at Serine 422 to Negatively Regulate Its Activity under Inflammation
- (2014) Zhiyuan Li et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Hematopoietic cell transplantation in patients with intermediate and high-risk AML: results from the randomized Study Alliance Leukemia (SAL) AML 2003 trial
- (2014) J Schetelig et al. LEUKEMIA
- Genome-scale expression and transcription factor binding profiles reveal therapeutic targets in transgenic ERG myeloid leukemia
- (2013) L. Goldberg et al. BLOOD
- Elevation of Receptor Tyrosine Kinases by Small Molecule AKT Inhibitors in Prostate Cancer Is Mediated by Pim-1
- (2013) B. Cen et al. CANCER RESEARCH
- The PIM Family of Serine/Threonine Kinases in Cancer
- (2013) Maja Narlik-Grassow et al. MEDICINAL RESEARCH REVIEWS
- Genomic and Epigenomic Landscapes of Adult De Novo Acute Myeloid Leukemia
- (2013) NEW ENGLAND JOURNAL OF MEDICINE
- The Pim kinase inhibitor SGI-1776 decreases cell surface expression of P-glycoprotein (ABCB1) and breast cancer resistance protein (ABCG2) and drug transport by Pim-1-dependent and -independent mechanisms
- (2012) Karthika Natarajan et al. BIOCHEMICAL PHARMACOLOGY
- Prognostic Significance of the European LeukemiaNet Standardized System for Reporting Cytogenetic and Molecular Alterations in Adults With Acute Myeloid Leukemia
- (2012) Krzysztof Mrózek et al. JOURNAL OF CLINICAL ONCOLOGY
- Acute Myeloid Leukemia (AML): Different Treatment Strategies Versus a Common Standard Arm—Combined Prospective Analysis by the German AML Intergroup
- (2012) Thomas Büchner et al. JOURNAL OF CLINICAL ONCOLOGY
- Prognostic Relevance of Integrated Genetic Profiling in Acute Myeloid Leukemia
- (2012) Jay P. Patel et al. NEW ENGLAND JOURNAL OF MEDICINE
- A potential therapeutic target for FLT3-ITD AML: PIM1 kinase
- (2011) Amir T. Fathi et al. LEUKEMIA RESEARCH
- Gene expression changes in peripheral blood mononuclear cells in occupational exposure to nickel
- (2010) Serena Bonin et al. EXPERIMENTAL DERMATOLOGY
- Why target PIM1 for cancer diagnosis and treatment?
- (2010) Nancy S Magnuson et al. Future Oncology
- Overexpression of Pim-1 is associated with poor prognosis in patients with esophageal squamous cell carcinoma
- (2010) Hong-Tao Liu et al. JOURNAL OF SURGICAL ONCOLOGY
- Pim-selective inhibitor DHPCC-9 reveals Pim kinases as potent stimulators of cancer cell migration and invasion
- (2010) Niina M Santio et al. Molecular Cancer
- Hypoxia-Mediated Up-Regulation of Pim-1 Contributes to Solid Tumor Formation
- (2009) Jian Chen et al. AMERICAN JOURNAL OF PATHOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More